制药行业支付荷兰医疗瘤学家的费用:开放式透明数据集提供的趋势和模式
J B Schnog1,2, M J Samson3, I Gersenbluth2
1Department of Hematology-Medical Oncology, Curaçao Medical Center, Willemstad, Curaçao.
荷兰的瘤科医生普遍存在金融利益冲突 (fCOI),随着时间的推移,支付费用正在下降. 关键意见领袖 (KOLs) 获得了更高的行业支付,突出了癌症治疗中的潜在偏见.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 医学伦理 医学伦理
背景情况:
- 癌症治疗的医疗保健成本上升,临床益处有限.
- 从药品 (药品) 支付给医生的金融利益冲突 (fCOI) 与低价值治疗有关.
- 需要评估荷兰对瘤学家的药品支付.
研究的目的:
- 确定向荷兰医疗瘤学家支付的药品支付的规模和财务价值.
- 调查关键论领袖 (KOLs) 的付款是否更频繁和更高.
主要方法:
- 跨截面的回顾性数据库研究.
- 利用荷兰开放访问数据库对2019-2021年的数据进行了分析.
- 提取并分析了对医疗瘤学家的支付数据.
主要成果:
- 在2019-2021年期间,899,863欧元支付给408名医疗瘤学家中的48.8%的医疗瘤学家.
- 瘤科医生收到支付的数量 (40.4%至19.1%) 和平均支付价值 (€2,962至€2,188) 显著下降.
- 关键论领袖 (KOLs) 更有可能获得更高的行业中位数支付.
结论:
- 这些发现突显了荷兰瘤学中fCOI的流行程度.
- 这项研究有助于提高人们对fCOI对癌症治疗的潜在影响的认识.
- 发现支付下降,但注意到对KOLs的支付持续上升.
更多相关视频
07:49Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Analysis of Population Pharmacokinetic Data
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
